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Bone marrow progenitors migrate to the thymus, where they proliferate and differentiate into
immunologically competent T cells. In this report we show that mice transgenic for SV40 T and t
antigens under the control of the L-pyruvate kinase promoter develop, in a ﬁrst step, thymic hyperplasia
of both thymocytes and epithelial cells. Morphological studies (histology, immunohistolabeling and
electron microscopy) revealed modiﬁcations of the thymic microenvironment and gradual expansion of
medullary epithelial cells in 1 month-old mice, taking over the cortical region. Then, a thymic
carcinoma develops. Two-color labeling of frozen sections identiﬁed the transgene in medullary
epithelial cells. Flow cytometry analysis demonstrated a marked increase in mature CD4
þ and CD8
þ
thymocytes in adult mice (39 ^ 10 £ 106 in transgenic mice and 12 ^ 5 £ 106 in age-matched
controls). Furthermore, thymocyte export was disturbed.
Keywords: Immunohistolabeling; Ultrastructure; Thymic medullary tumor; L-pyruvate kinase
promoter
Abbreviations: DN, double negative CD4
2CD8
2; DP, double positive CD4
þCD8
þ; SP, single
positive CD4
þCD8
þ; SV40, simian virus 40; Tag, T antigen; TCR, T cell receptor; Tg, transgenic
INTRODUCTION
In the thymic microenvironment, the epithelial compart-
ment is organized into cortical and medullary zones that
mediate different aspects of thymocyte differentiation.
The different processes controlling the growth and
organization of the epithelial compartment depend largely
on cell interactions involving thymocytes and stromal
cells for selection, differentiation and maturation of
T cells (Duijvestin et al., 1981; Weissman et al., 1982;
Kendall, 1986; Nabarra, 1987; 1991a; Marrack, 1988;
von Bohmer, 1988; Sprent et al., 1988; Brekelmans and
van Ewijk, 1990; van Ewijk, 1991; Boyd et al., 1993).
Furthermore, thymic stroma cells included also non-
epithelial cells (bone marrow-derived cells) as macro-
phages and interdigitated cells (IDC) which are also
involved in these process.
In this milieu, thymocytes are in symbiotic develop-
mental relationship involving the different stromal cells
and various signaling molecules, cytokines, cytokine
receptors and chemokines (Zlotnik and Moore, 1995;
Norment and Bevan, 2000). T cell precursors migrating
from the bone-marrow to the thymus undergo an ordered
differentiation process. After different migrations steps
across the organ, mature T cells are generated and exit the
thymus for the periphery (Scollay et al., 1980; Pe ´nit,
1986). Migration and homing are partly dependent on
adhesion molecules (Imhof et al., 1991; Aurrand-Lions
et al., 1996). Virtually nothing is known about the precise
thymic location from which mature thymocytes emigrate
from the thymus to peripheral lymphoid organs. However,
the cortico-medullary junction has been suggested
important in this process in association with maintenance
of a normal architecture.
The studies of all these parameters, particularly
elucidation of the cross-talk between thymocytes and
epithelial cells (van Ewijk et al., 1994; Pe ´nit et al., 1996),
is difﬁcult to appreciate in steady state conditions.
Nevertheless, the studies of modiﬁcation and disruption of
the thymic microenvironment organization in different
pathologic mice, and recently of genetically engineered
mice, appeared to be a good approach in relation with
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developmental program and phenotype of thymocytes
(Rouse and Weissman, 1981; Kendall, 1986; Nabarra and
Dardenne, 1991b; Naquet et al., 1999).
In this way, both naturally occurring and experimen-
tally-induced tumors were used as models for dissecting in
vivo these different sequences of T cell education, and
disruption of thymic stroma.
Transgenic model of pure thymic tumor is rarely
described. Today only one team has described a thymic
carcinoma issued of an extanded thymic hyperplasia in Tg
mice made with SV40 Simian Virus T antigen 40 (SV40)
associated with it own promoter (Park et al., 1996; Lee
et al., 1998).
We have generated a second mouse model with SV40 T
and t Ag with a different promoter (L-pyruvate kinase).
SV12 transgenic mice develop early in life a massive
thymic hyperplasia concerning both thymocytes and
epithelial cells. Immuno-histological studies, conﬁrmed
by electron microscopy studies, demonstrate a large
hyperplasia of expanded medullary epithelial cells,
carrying the transgene. With time, large angiogenesis,
numerous cellular atypies concerning the cytoplasm and
the nucleus and a large thymic epithelial tumor of
carcinoma type with formation of necrotic nodules are
observed (Nabarra, in preparation). Thymocyte differen-
tiation was stable, but resulted in increased numbers of
mature single-positive (SP) thymocytes. The impact of
this modiﬁed microenvironment on thymic maturation and
export is discussed.
RESULTS
Generation of SV12 Transgenic Mice
The structure of the fusion genes was described previously
and has been published (Miquerol et al., 1996).
Transgenic mice were generated by microinjecting DNA
into the pronucleus of fertilized mouse eggs. Newly
integrated sequences were identiﬁed after hybridization of
tail DNA with a probe for SV40 T Ag. Three transgenic
mouse lines, with different transgene copy numbers
(SV12, SV19, SV25), which all carried SV40 T antigen
genes in the germ line, were obtained. The SV12 line is
characterized by a rapidly growing thymic tumor: thymus
weight is 1.6g at 16 weeks, compared to 0.05g in
age-matched controls. The SV10 line develops a thymic
tumor of the same size as that in SV12 mice, but much
later (around 8 months); the SV25 line is intermediate, as
the thymic tumor develops at 6 months. It is unclear why
such promoter can lead to thymic tumors. We have
focused this study on the SV12 line.
SV12 Thymic Microenvironment (1–4 Months)
The morphological aspect of the thymic stromal cells, in
the ﬁrst months of life, is described here, at the stages of
large hyperplasia and beginning of tumor development
when the malignancy is not obvious.
Medullary Epithelial Cell Expansion and
Disorganization of the Thymic Stroma
We observed from the ﬁrst weeks of life, a large
hyperplasia concerning both the stroma cells and the
lymphocytes without alterations of the architecture.
At 2 months, the thymic microenvironment was
disorganized regarding location of cortical and medullary
areas. Histological staining showed a marked development
of the medulla, largely extended to the capsule, alternating
with narrow and remained area of the cortical zone, giving
an inverted picture (Fig. 1a) compared to the normal
thymus. Numerous lymphoid cells were present in all
these stromal areas. High mitotic activity was detected.
Labeling with MTS10 antibody shows several large
positive medullary zones going under the capsula and
shifting in unusual location reduced cortical spots labeled
with MTS5 antibody (Fig. 1b–d). Later on, and on
classical histologic staining, the presence of round and
clear cells with a large nucleus, scattered and/or in small
groups was observed around 4 months, associated with
fewer thymocytes but with always numerous mitoses. The
vascular network was modiﬁed and many neo-vessels
appeared in the hyperplasic parenchyma as focused
toward the formations of clear cells (Fig. 1e). These
numerous neo-vessels are labeled with CD31 (speciﬁc of
endothelial vascular cells) (Fig. 1f) showing an important
angiogenesis process.
Ultrastructural examination conﬁrm the abnormal
composition of the thymic microenvironment with an
increasing number of epithelial cells of medullary type
(type III and IV immature cells) (Nabarra, 1987;1991a)
(Fig. 2a–c). In a second step some unclassiﬁed cells
FIGURE 1 (a) Histology of SV12 mice at 2 months showing the altered distribution of the medullary zone (clear staining) and the cortical zone, with
more numerous strongly colored lymphocytes. Trichrome staining. X400. (b) MTS-5 labeling showing the modiﬁed and reduced repartition of the
“cortical” areas in 2 month-old SV12 mice. X400. (c) MTS-10 labeling of medullary epithelial cells of the modiﬁed thymic microenvironment in
2 month-old SV12 mice. X400. (d) Labeling with MTS-10 antibody at 4 months, showing groups of medullary epithelial cells extending under
the capsule and, in down right area, a large “white” zone (MTS10 labeling) with a few isolated MTS-10
þ cells. X400. (e) Histological aspect at 4 months
in an area of thymic hyperplasia, with numerous clear round cells crossed by numerous neovessels organized toward “nodular” cellular clear areas
(down right). Trichromestaining. X400.(f) Aspect at 4 monthsin SV12mice, showinga largeincrease in the number of small vessels labeled with CD31
X400. (g) Low magniﬁcation of the thymic microenvironment in 2 month-old SV12 mice showing, scattered in the stroma, numerous cells labeled with
monoclonal antibodies against SV40 Tantigen. X400. (h) Double immunolabeling with SV40 and MTS-10 antibodies, revealing majority of cells with
jointly the transgene stained in blue on nucleus and medullary epithelial cells stained brown by peroxidase. X1000. (i) Double immunolabeling
with SV40 Tand N418 antibodies. The blue nucleus with a strongly labeled nucleolus is not associated with peroxidase brown cells corresponding to the
interdigitated cells (N418). X1000.
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desmosomes) but without other speciﬁc morphological
characteristics appeared to be undifferentiated (Fig. 3a).
Numerous lymphocytes and lymphoblasts with a larger
cytoplasm containing a high number of ribosomes were
present especially at 2 months. Mitosis were frequent in
both epithelial cells and lymphocytes (Fig. 3a).
Numerous vessels in formation with turgescent endo-
thelium were found in this modiﬁed thymic parenchyma
(Fig. 3b).
Finally from 4 months, numerous cellular atypies
concerning both cytoplasm and nucleus were noted (not
shown).
Transgene Expression is Limited to Medullary
Epithelial Cells
To determine which subset of epithelial cells expressed
the transgene, immunohistolabeling studies were per-
formed with anti-T SV40 antibody on frozen sections.
Two- and four-month-old SV12 mice showed dense
staining of numerous cells, mostly grouped in large zone
but a few number was scattered throughout the thymus
parenchyma (Fig. 1g). High magniﬁcation revealed
labeling of dense clumps in the nucleus of large cells,
and sometimes a discreet staining of the stellate
cytoplasm. This clearly indicated that epithelial cells
were SV40
þ.
Dual immunolabeling with anti-SV40 T and MTS-10
antibodies revealed that the transgene (staining blue
clumps in the nucleus) was present in most medullary
epithelial cells (labeled by brown peroxidase) (Fig. 1h).
Thus, SV40
þMTS-10
þ medullary epithelial cells were
observed in large areas of the modiﬁed thymic
architecture. Very few SV40
þ cells were not labeled by
the MTS10 antibody.
Dual labeling with SV40 and N418 (chieﬂy a marker of
interdigitated cells) showed that interdigitated cells were
increased in number and scattered throughout the
modiﬁed microenvironment, and that none of these cells
expressed SV40 (Fig. 1i).
FIGURE 2 Ultrastructural aspect of the different types of thymic
medullary epithelial cells: (a) Type II epithelial cell (arrow head:
tonoﬁlament) with the characteristic intracytoplasmic “alveolar
labyrinth”. Impregnated by uranyl acetate and lead citrate. X12500. (b)
Type III epithelial cell with an intracytoplasmic cavity having a lumen
full of dense contains and bordered by microvillosities and numerous
cilia. Impregnated by uranyl acetate and lead citrate. X12000. (c)
Immature epithelial cells (Type IV) with very light tonoﬁlaments and
small desmosomes in a clear cytoplasm (arrow head). Immature nucleus
with a clear coarse chromatin and dense reticuled nucleolus are present.
Impregnated by uranyl acetate and lead citrate. X16500.
FIGURE 3 (a) Large and extended epithelial cytoplasm (presence of
tonoﬁlaments) with numerous ribosomes and without morphological
characteristics. They appear less differentiated. At the bottom of the
micrograph, an epithelial cell (forming desmosomes) in mitosis.
Impregnated by uranyl acetate and lead citrate. X18000. (b) Head of a
new vessel with red blood cells (*), turgescent endothelium and basal
membrane in formation (arrow head). Epithelial cells and lymphoblasts
are present in the environment. Impregnated by uranyl acetate and lead
citrate. X22000.
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Increased Mature Thymocyte Numbers
Thirty-two transgenic mice and 31 controls were studied
between 4 weeks and 6 months of age. The phenotype of
the mice had been stable for more than 18 generations.
Most mice die around 5–6 months of age most probably
by asphyxia due to thymic outgrowth. Fig. 4 shows the
kinetics of thymic cellularity in SV12 and control mice:
between 6 and 8 weeks SV12 mice show a signiﬁcant
increase in total cell numbers; maximum thymus size is
reached around 12 weeks and remains constant thereafter.
No difference in proliferation (assessed by BrdUrd
incorporation) was observed between SV12 and control
thymuses (data not shown). As shown in Fig. 4,
lymphadenopathy was observed after 2 months of age in
SV12 mice, and Tand B cell numbers were increased in all
lymph nodes. Thymocyte subsets were then analyzed to
further characterize the phenotype of the SV12
transgenic line.
Thymocyte differentiation was very stable in SV12
mice throughout the study. All four thymic subsets were
always present. The relative proportion of the most
immature population (CD4
2CD8
2) was similar in SV12
and controls, but the CD4
þCD8
þ (DP) population was
decreased in SV12 (Fig. 5a, (a and e)). Marked CD25
expression by the DP subset was always found (Fig. 5a,
(c and g)); thus, it reveals incomplete down regulation of
CD25 from the triple negative 3 (TN3 subset, CD25
þ
CD44
2) subset for an unknown reason. Analysis of
mature thymic subsets revealed larger numbers of
TCRab
þ thymocytes in SV12 (Fig. 5a, (f)) than in
aged-matched controls (Fig. 5a, (b)).
The numbers of CD4
þ- and CD8
þ-TCRab
þ mature
TcellsbecamesigniﬁcantlyhigherinSV12thanincontrols
around2monthsofage(Fig.4and5b).Down-regulationof
HSA antigen expression reﬂected the complete maturation
of TCRab
þ thymocytes (Fig. 5a, (d and h)). These
populations showed normal expression of activation
markers (CD69, CD44, CD25, CD62L) (not shown).
Moreover, Vb subsets among mature T cells were normal
(not shown). The accumulation of mature thymocytes
couldreﬂectdefectivehomingand/orspeciﬁcoutgrowthof
thissubset,butthymocyteproliferativeactivitywasnormal
in SV12 mice (not shown).
Thymic Export is Disturbed in SV12 Mice
The marked thymic hyperplasia observed as early as
6 weeks and involving both thymocytes and epithelial
cells, together with the increase in mature thymocyte
numbers prompted us to analyze the output of mature
T cells. Injection of ﬂuorescein into the thymic lobes
allowed us to analyze thymic export to lymph nodes.
As shown in Table I, at 1 month and 5 months of age the
number of thymic emigrants was higher in SV12 mice
than in controls. However, the ratio of thymic emigrants
to mature thymocytes revealed a very low level of
thymocyte release in SV12 mice compared to controls,
and this defect increased with age. Thus, thymic export is
altered in SV12 mice since more thymocytes were
expected to emigrate.
DISCUSSION
In SV12 Tg mice, the thymus becomes hyperplasic
concerning both stromal cells and lymphocytes. We show
a very large extension of the medullary epithelial cells
which carried exclusively the transgene. In this modiﬁed
microenvironment mature single positive CD4
þ and
CD8
þ thymocyte numbers increase. Furthermore, analysis
of thymic export in SV12 mice shows a signiﬁcant
reduction in T cell emigration. Altogether, these results
suggest that the altered medullary environment in SV12
transgenic mice supports normal thymocyte differen-
tiation but disturbs thymic export.
We will focus our discussion on the thymocyte
populations and their relationship with the different
cellular components of the stromal microenvironment,
especially the medullary epithelial cells in the hyper-
plasic stage.
We note ﬁrstly that in several SV40 T Tg mouse
models, thymic hyperplasia is sometimes associated with
FIGURE 4 Cellularity in SV12 thymus and lymph nodes with age. Age-dependent cellularity in thymus (a) and lymph nodes (b) in SV12 mice and
littermate controls. Mean values ^ SD of 6 to 8 animals. SV12 (X), CBA littermates (W).
THYMOCYTE DIFFERENTIATION IN SV40 Tg MICE 227tumor development invarious other organs (Brinsteret al.,
1984; Palmiter et al., 1985; Botteri et al., 1987; Reynolds
et al., 1988; Messing et al., 1988; Teitz et al., 1995).
In these reports, the hyperplasia appeared lymphocytic
with an eventual alteration of the stroma rarely studied.
It is noted an increase in lymphocyte numbers with normal
subset representation. These authors suppose that the
lymphocyte proliferation is in relation with the stromal
cell modiﬁcations. In the model of thymic tumor reported
by Park et al. (1996) an increase in total lymphocyte
TABLE I Thymic export is altered in SV12 transgenic mice
Age of mice Number of thymic emigrants per day ( £ 10
26) Ratio of thymic emigrants/mature thymocytes
1 month Experiment 1 Tg
2 0.26 1/68
Tg
+ 0.79 1/228
Expe ´riment 2 Tg
2 0.82 1/19
Tg
2 0.63 1/26
Tg
+ 1.34 1/15
Tg
+ 1.15 1/26
5 months Experiment 1 Tg
2 0.73 1/9
Tg
2 2.44 1/6
Tg
+ 4.04 1/107
Experiment 2 Tg
2 0.45 1/5
Tg
+ 7.52 1/79
Tg
+ 1.92 1/183
At the age indicated, mice received an intrathymic injection of FITC as described in Materials and Methods section. Eighteen hours later, thymus, spleen and lymph nodes
were analyzed by FACS for the presence of FITC
þ cells.
FIGURE5 Thymicdifferentiationin SV12Mice. (a) Comparisonofthymocyte subpopulations ofCBA(a–d)and SV12(e–h) mice.Thymocytes were
analyzed by two-color cytometry for expression of TcR vs. HSA (d, h) or by three-color cytometry for CD4, CD8 and TcR (a, b, e, f) or CD25 (c, g). In b
and f, the proﬁles show TcR expression in total thymocyte population; in c and g, the proﬁles show CD25 expression on gated CD4
þCD8
þ cells.
Numbers indicate percentages of cells. (b) Age-dependent percentage of single positive cells (CD4
þCD8
2 and CD8
þCD4
2) in thymus (a) and lymph
nodes (B) in SV12 mice and littermate controls. CD4
þCD8
2 and CD8
þCD4
2 phenotypes are visualized by double staining of thymocytes with PE anti-
CD4 and FITC anti-CD8 antibodies. Mean values ^ SD of 3–6 animals. SV12 (X), CBA littermates (W).
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stromal cell modiﬁcations but not characterized.
In our model, expression of the transgene by medullary
epithelial cells is associated with marked proliferation of
this cell type. This large proliferation is responsible for the
disruption of the thymic architecture, with loss of
organization, disruption of the cortico-medullary junction
and marked expansion of medullary cells. Blockade of
different tumor suppressor factors might induce epithelial
proliferaton (Hanaban et al., 1985; Ludlow, 1993; Robles
et al., 1994). The epithelial cells appeared directly
involved in the observed lymphocytic hyperplasia. Indeed,
bone marrow transplantation from transgenic mice to
irradiated non transgenic recipients leads to the develop-
ment of a normal thymus (data not shown). Cytokines and
growth factors are produced by transformed epithelial
cells (Moll et al., 1992; Fass et al., 1993), and the
thymocyte hyperplasia observed in the SV12 line could be
due to these stimulating factors, which could act by
enhancing cell growth and/or survival.
The exact role of thymic stroma cells in T cell
maturation and selection of the T cell repertoire is unclear.
Thymocyte development in SV12 mice is remarkably
stable, with an age-related increase in mature thymocyte
numbers; this subset is increased in percentage and
absolute number. The microenvironment contributes to the
maintenance of mature thymocytes in speciﬁc cross-talk
interactions. Thus, T cells or/and their immediate stromal
partners might be defective. Abnormal thymocyte antigen
expression may prevent thymic export. However, CD62L
expression is normal on SV12 thymocytes (data not
shown); therefore, involvement of other molecules in
thymic emigration and/or of endothelium-thymocyte
interactions might play a role (Yagi et al., 1996). The
absence of any detectable defect at the lymphocyte level
strongly points to stromal malfunction. However, it does
not interfere with thymocyte differentiation; mechanical
constraints due to a disorganized network of epithelial
cells are probably involved. Reports of SV40-induced
cortical epithelial tumor development also showed an
increase in mature T cells (Park et al., 1996; Lee and Seo,
1996). It is assumed that all maturing thymocytes exit
from the cortico-medullary junction, thus this process
might be hindered by disruption of this junction during
medullary (our report) or cortical (Lee and Seo, 1996)
epithelial expansion. The exit failure described in the
SV12 model is present as early as 1 month, before
peripheral T cell hyperplasia.
However, we cannot exclude that other mechanisms
(as homeostatic mechanisms) play a role. For example,
in another study (Volkmann et al., 1996), thymic
hyperplasia with increased production of thymocytes and
increased export of T cells results in a normal size of the
peripheral T cell pool. Thus, disregulation of the export is
largely dependent on the in situ thymic environment.
Another hypothesis considers that thymocytes could also
act by enhancing cell growth and/or survival on the
epithelium, which may respond to signals produced by
the overproliferating lymphocytes in these tumors. This
can be supported by works claiming that the development
of the medullary zone involves the presence of mature
T cells (Surh et al., 1992). But it is accepted that
hyperplasiaisnotanautonomouspropertyofmutantTcells
and it is rather likely that the modiﬁed microenvironment
involves inappropriate epithelial factors or cell–cell
contacts and the increase, as a consequence, of the number
of lymphocytes in the thymic stromal compartment.
Our study shows a new model among SV40 transgenic
mice. For the ﬁrst time we clearly show that the transgene
is expressed in the thymic medullary epithelium, and that
mature thymocyte accumulation is due to a disturbed
thymic export. Thus, the expanded medullary epithelium
might have lost a critical organization directing the export
process. SV12 mice should prove useful for studies of the
mechanism underlying thymocyte emigration.
MATERIALS AND METHODS
Mice
The SV12 transgenic line was generated at Cochin
Hospital by A. Kahn’s team (Miquerol et al., 1996). The
transgene encodes T and t antigens from SV40 (2.7Kb
fragment of the simian virus genome) under the control of
the pyruvate kinase promoter (Cla I/EcoRv fragment) and
the SV40 enhancer (270–95 nt fragment). Three
independent transgenic lines were obtained (SV25,
SV19 and SV12) according the copy number integrated
in the genome. SV12 females are infertile, and the line is
thus maintained by crossing heterozygous SV12 Tg males
with CBA females. Controls are non transgenic litter-
mates. Mice were tested for the presence of the transgene
by means of PCR on DNA extracted from tail biopsy
specimens. The primer SVS3 and PK-L sequences are:
- SVS3: 50GCATCCCAGAAGCCTCCAAAG30,
- PK-L:50GCA ACGTAGCAGCATGGAAG30.
Tail DNAwas incubated in 50ml of Taq buffer solution
(ATGC) with dNTP (1mM), 0.5unit of Taq polymerase
and 0.1mg of each primer. The ampliﬁcation sequences
consisted of 8min at 948C then 30 cycles at 928C (3000),
558C (3000) and 728C( 1 0). The last cycle is followed by
incubation at 728C for 50.
Monoclonal Antibodies
The following antibodies were used for cytometric
analysis: anti-CD4 (clone GK 1.5), anti-CD8 (clone 53-
6.7), anti-ab-TCR (clone H57-597), anti-CD25 (clone
PC61), anti-CD44 (clone Pgp1), anti-CD24 (clone J11d)
and anti-B220 (clone RA3-6B2). They were purchased
from Pharmingen (Becton Dickinson, Grenoble, France)
THYMOCYTE DIFFERENTIATION IN SV40 Tg MICE 229or prepared in our laboratory from hybridomas and used as
directly coupled to ﬂuoresceine thyocyanate (FITC) or
phycoerythrin (PE) or cychrome (Cy) and if coupled to
biotin, detected by streptavidin-Cy.
The following antibodies were used for immunolabel-
ing studies with different dilutions: MTS5 (1:20) (against
cortical epithelial cells) (Boyd et al., 1993), MTS10
(1:100) (against medullary epithelial cells) (Boyd et al.,
1993), anti-CD31 (1:200) (speciﬁc for endothelial
vascular cells), anti-SV40 T coupled to biotin (1:800)
(Pharmingen); N418 (pure) (speciﬁc for interdigitated
cells) was a kind gift from G. Kraal (Vrije University,
Amsterdam, The Netherlands).
The second step uses mouse anti-rat biotin (MAR)
(1:40, Immunotech), mouse anti-hamster biotin (MAH)
(1:100, Pharmingen) or TSA-biotin system (NEN Life
Science Products).
The third step is 3-30 diaminobenzidine (Fast DAB,
Sigma) for MTS5, MTS10 and CD31 and Elite
ampliﬁcation kit (Vector Laboratories) for N418. Strepta-
vidin-peroxidase (Vector Laboratories) was also used to
detect biotinylated antibodies.
Morphological Techniques
Dissected thymic tissues were immediately fragmented
and prepared for three techniques.
Histology: The thymuses of 12 mice in each age
group (1–6 months) were ﬁxed in Bouin’s solution for
12h and included in parafﬁn, then sections of 3 microns
were stained with hematoxylin eosin, Masson trichrome
and PAS.
Immunohistology: Fragments were placed in cryovials
(Greiner) and quickly placed in liquid nitrogen. Frozen
sections (5 microns) were ﬁxed for 10min in acetone at
room temperature and air-dried. For single-color labeling,
in the ﬁrst step, antibodies were incubated for 1h at room
temperature. For the second step, the incubation is of
30min, followed by the third step described previously.
Double labeling is performed with SV40-biotin (1:40)
in the ﬁrst step or MTS10 (1:100) or N418 (pure) in a
second step followed by Elite ampliﬁcation kit (for
SV40), MAR-bio (for MTS10) or MAH (for N418); last
step includes VSG (Vector Laboratories) for SV40 or
Elite ampliﬁcation kit and Nova Red (Vector Labora-
tories) for MTS10 and N418. For all, rehydratation and
washes were performed with PBS þ 5% FCS. Slides were
mounted in Entellan.
Electron microscopy: Small fragments of different
thymuses were ﬁxed in 1.6% glutaraldehyde in Sorensen’s
buffer þ 9% NaCl, pH 7.4, for 1h. After three washes in
the same buffer they were post-ﬁxed in 1% osmium
tetroxide for 1h. After washing, the fragments were
dehydrated in a series of alcohol and propylene oxide and
embedded in EPON 812 resin (Polysciences). Ultrathin
(700A ˚) sections were cut, places on copper grids and
impregnated with uranyl acetate and lead citrate for
examination in a Philips EM 300 electron microscope.
Twelve mice at each age (1–6 months) were used for
morphologic studies.
Emigration Assay
The test was performed as described by Scollay et al.
(1980), except that 20–50ml of FITC solution at 1mg/ml
in PBS was intrathymically injected into one thymic lobe,
owing to the large size of the thymuses. Mice were killed
16h later and their thymus, spleen and lymph nodes were
removed.Between20and50%ofthymocyteswereFITC
þ.
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